Unlike everyday supplements stocked in every health store, CJC-1295 reaches researchers through a specialist research supply market that Wing residents reach through online vendors. The upside of this online-only market is that serious vendors differentiate entirely through their analytical documentation, giving researchers more rigorous quality data than any physical store could provide. What consistently distinguishes top CJC-1295 vendors is complete batch-specific analytical documentation: HPLC for purity, mass spec for molecular identity verification, and endotoxin testing for safety documentation. This guide guides Wing researchers through that evaluation process and explains what quality documentation for CJC-1295 should look like.
CJC-1295 Mechanisms Explained
CJC-1295 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Wing studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
How to Source CJC-1295 — Vendor Guide
The most effective path to quality CJC-1295 is engaging research communities before vendor sites — peptide forums track vendor quality over time that are more accurate than commercial vendor claims. Endotoxin testing in the COA is critical for any injectable research use — endotoxins from microbial contamination can trigger dangerous inflammatory cascades even at very low concentrations. Positive vendor signals beyond COA quality: multi-year operating history, knowledgeable support capable of explaining COA data, and temperature-appropriate packaging with desiccant. The powdered lyophilised form of CJC-1295 is much more stable than liquid pre-made solutions — lyophilised powder stays viable for years at −20°C, while liquid preparations lose activity within weeks.
Order CJC-1295 — ships to Wing
COA-verified · International tracking · Research grade
All use of CJC-1295 in Wing or anywhere constitutes research use — this compound is not approved for human therapeutic use, and all handling should adhere to research compound handling standards. Storage requirements for CJC-1295: lyophilised powder at −20°C, reconstituted solution stored refrigerated at 2-8°C and finished within 30 days of reconstitution; reconstitute only with bacteriostatic water. Quality CJC-1295 sourcing is inseparable from safety — bacterial endotoxin contamination, wrong peptide identity, and degraded material are all safety issues that proper COA verification addresses. The research literature on CJC-1295 should be reviewed carefully before designing any protocol — study designs, dosing ranges, and outcome measures vary significantly and not all findings translate directly.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
